IP Library Granted Patent US 9,611,507
Granted Patent B2
US 9,611,507 · App. 14/486,598 · Granted Apr 4, 2017

Arrays of microparticles and methods of preparation thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,611,507
App. No.
14/486,598
Granted
Apr 4, 2017
Kind
B2
Abstract

This invention provides high unit density arrays of microparticles and methods of assembling such arrays. The microparticles in the arrays may be functionalized with chemical or biological entities specific to a given target analyte. The high unit density arrays of this invention are formed on chips which may be combined to form multichip arrays according to the methods described herein. The chips and/or multichip arrays of this invention are useful for chemical and biological assays.

Claims (20)

1. A biochip comprising a semiconductor wafer substrate having a multiplicity of bead arrays within delineated compartments positioned thereon and having separating boundaries between said delineated compartments,

wherein each bead array comprises a set of biofunctionalized beads and wherein the biofunctionalized beads are optically encoded such that bead subpopulations having different biomolecules attached thereto are distinguishable by optical analysis; and

wherein each of the delineated compartments comprises recess structures for housing the biofunctionalized beads, wherein the structures each comprise a recess surface opening and a recess bottom, and wherein the recess surface opening comprises a smaller diameter than the recess bottom.

2. The biochip of claim 1 , wherein the separating boundaries comprise scribe lines.

3. The biochip of claim 1 , wherein the biofunctionalized beads comprise one or more biomolecules selected from the group consisting of oligonucleotides, nucleic acid fragments, proteins, oligopeptides, ligands, receptors, antigens, antibodies, individual members of biological binding pairs, and combinations thereof.

4. The biochip of claim 1 , wherein the structures are substantially occupied by biofunctionalized beads.

5. The biochip of claim 1 , wherein the structures are each sized so as to accommodate one bead.

6. The biochip of claim 1 , wherein the structures are each sized so as to accommodate multiple beads.

7. The biochip of claim 1 wherein the structures comprise triangular, rectangular, pentagonal, hexagonal, circular shapes or a combination thereof.

8. The biochip of claim 1 , wherein the structures have a depth of about 0.5 to 1.5 times the diameter of the beads.

9. The biochip of claim 1 , wherein each bead array comprises the same set of biofunctionalized beads.

10. The biochip claim 1 , wherein the multiplicity of bead arrays comprises at least two different sets of biofunctionalized beads.

11. The biochip of claim 1 , wherein each delineated compartment is associated with a decodable tag that identifies the semiconductor wafer substrate.

12. The biochip of claim 1 , wherein the biofunctionalized beads are affixed to the substrate by covalent bonds, van der Waals forces, electrostatic forces, gravitational forces, magnetic forces, or a combination thereof.

13. The biochip of claim 1 , wherein the biofunctionalized beads comprise plastic, ceramic, or glass beads or a combination thereof.

14. The biochip of claim 1 , wherein the biofunctionalized beads have diameters of from about 0.2 micron to about 200 microns.

15. The biochip of claim 1 , wherein the optical analysis comprises analysis of one or more of excitation wavelength, emission wavelength, excited-state lifetime, and emission intensity.

16. The biochip of claim 1 , further comprising a removable protective coating covering the multiplicity of bead arrays.

17. The biochip of claim 16 , wherein the removable protective coating comprises an inert, non-reducing sugar or a hydrogel.

18. A plurality of chips prepared by singulation of the biochip of claim 1 along the separating boundaries.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0033 →
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0111 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0135 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: ALTER DOMUS (US) LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0152 →
RELEASE OF PATENT SECURITY INTERESTS Recorded Jul 2, 2020
From: CITIBANK, N.A.
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.; SIRONA GENONICS, INC.
Reel/Frame 053121/0935 →
SECURITY AGREEMENT Recorded Jul 21, 2017
From: BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 043288/0785 →